X Lab Series · Preparation process
Dendritic cells,for cancer immunotherapy.
Dendritic cells (DCs) are antigen-presenting cells used in cancer immunotherapy and therapeutic vaccines. CellAuto prepares them on a closed, automated line, from blood collection to a released product ready for reinfusion.
Overview
What they are
Dendritic cells are the immune system’s antigen-presenting cells. When loaded with tumour antigens they can prime a targeted immune response, which makes them valuable in cancer immunotherapy.
Why automate it
DC preparation involves isolation, extended culture and processing that are sensitive to handling. A closed automated line keeps the process sterile, consistent and traceable.
Where it is used
Cancer immunotherapy and therapeutic cancer vaccines, in clinical research and scaled production.
The automated process
The steps above follow CellAuto’s standard automated dendritic-cell workflow. Culture and antigen-loading protocols are configured and validated for each specific product and site.
Core platform systems
Every transfer between steps is made through a closed, aseptic connection, so the cells stay in a sealed path from start to finish. The exact configuration is agreed during project planning.
Bring this processonto an automated line.
Tell us the cell type, the batch size and the facility, and we will tell you what the automated preparation looks like for you.